Enliven Therapeutics (ELVN) Institutional Ownership

$60.50 -0.37 (-0.61%)

Closing price 04:00 PM Eastern

Extended Trading

$62.00 +1.50 (+2.48%)

As of 07:30 PM Eastern

Compare

Current Institutional Ownership Percentage: 95.08%
Number of Institutional Buyers (last 12 months): 85
Total Institutional Inflows (last 12 months): $800.43M

Number of Institutional Sellers (last 12 months): 33
Total Institutional Outflows (last 12 months): $184.08M

Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/26/2026	Amundi	6,041	$307K	0.0%	-12.9%	0.008%
8/24/2026	California State Teachers Retirement System	2,705,736	$137.32M	0.0%	+8,378.2%	3.693%
8/21/2026	AXQ Capital LP	10,095	$512K	0.1%	-5.1%	0.014%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	80,072	$4.06M	0.0%	+18.7%	0.109%
8/19/2026	Wellington Management Group LLP	133,143	$6.76M	0.0%	-11.3%	0.182%
8/17/2026	Capstone Investment Advisors LLC	10,577	$537K	0.0%	N/A	0.014%
8/17/2026	Seven Fleet Capital Management LP	365,386	$18.54M	3.1%	+40.9%	0.499%
8/17/2026	Artia Global Partners LP	72,100	$3.66M	0.7%	N/A	0.098%
8/17/2026	Bamco Inc. NY	7,500	$381K	0.0%	N/A	0.010%
8/17/2026	Bank of America Corp DE	98,023	$4.98M	0.0%	N/A	0.134%
Get the Latest News and Ratings for ELVN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/15/2026	Jupiter Topco LLC	604,122	$30.62M	0.0%	N/A	0.825%
8/15/2026	J. Goldman & Co LP	112,129	$5.69M	0.1%	N/A	0.153%
8/14/2026	ADAR1 Capital Management LLC	387,718	$19.68M	0.9%	N/A	0.529%
8/14/2026	Canada Pension Plan Investment Board	15,400	$782K	0.0%	N/A	0.021%
8/14/2026	Nicholas Investment Partners LP	391,529	$19.87M	1.1%	N/A	0.534%
8/14/2026	Legal & General Group Plc	32,924	$1.67M	0.0%	N/A	0.045%
8/14/2026	The Manufacturers Life Insurance Company	75,265	$3.82M	0.0%	N/A	0.103%
8/14/2026	Spruce Street Capital LP	329,006	$16.70B	3.3%	N/A	0.449%
8/14/2026	Algert Global LLC	72,090	$3.66M	0.0%	N/A	0.098%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	160,879	$8.17M	0.0%	N/A	0.220%
8/7/2026	BlackRock Inc.	4,359,704	$221.26M	0.0%	N/A	7.159%
8/7/2026	Deutsche Bank AG	45,109	$2.29M	0.0%	N/A	0.074%
8/7/2026	TimesSquare Capital Management LLC	261,344	$13.26M	0.2%	N/A	0.429%
8/7/2026	Persistent Asset Partners Ltd	9,433	$479K	0.1%	N/A	0.015%
8/6/2026	Bank of New York Mellon Corp	118,853	$6.03M	0.0%	N/A	0.195%
8/6/2026	State of Wyoming	1,884	$96K	0.0%	N/A	0.003%
7/10/2026	Tema ETFs LLC	60,694	$3.08M	0.1%	+41.0%	0.100%
7/10/2026	Handelsbanken Fonder AB	17,300	$878K	0.0%	N/A	0.028%
7/8/2026	FNY Investment Advisers LLC	2,500	$126K	0.0%	N/A	0.004%
7/8/2026	Assenagon Asset Management S.A.	306,574	$15.56M	0.0%	N/A	0.503%
6/4/2026	Seven Fleet Capital Management LP	259,283	$10.16M	3.2%	+159.4%	0.426%
6/3/2026	DV Trading LLC	95,253	$3.73M	0.1%	N/A	0.156%
5/28/2026	Avidity Partners Management LP	400,000	$15.68M	3.1%	+185.1%	0.657%
5/19/2026	Bank of America Corp DE	45,162	$1.77M	0.0%	+38.1%	0.074%
5/19/2026	Stempoint Capital LP	363,438	$14.25M	2.7%	N/A	0.597%
5/19/2026	Janus Henderson Group PLC	11,000	$431K	0.0%	-99.3%	0.018%
5/18/2026	ADAR1 Capital Management LLC	329,540	$12.92M	0.8%	+998.5%	0.541%
5/18/2026	Amundi	6,936	$272K	0.0%	N/A	0.011%
5/18/2026	California State Teachers Retirement System	31,914	$1.25M	0.0%	-0.9%	0.052%
5/18/2026	Royal Bank of Canada	5,424	$212K	0.0%	+345.0%	0.009%
Iran War Shock: What I Was Told In That Private Meeting (Ad) You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country. Because THIS is the real reason.
5/18/2026	Rock Springs Capital Management LP	826,500	$32.40M	1.9%	+3.5%	1.357%
5/18/2026	Exome Asset Management LLC	220,091	$8.63M	4.5%	-1.0%	0.361%
5/16/2026	The Manufacturers Life Insurance Company	23,441	$919K	0.0%	+21.2%	0.038%
5/16/2026	Quantinno Capital Management LP	6,538	$256K	0.0%	N/A	0.011%
5/16/2026	First Light Asset Management LLC	201,867	$7.91M	0.7%	N/A	0.331%
5/16/2026	SummitTX Capital L.P.	68,706	$2.69M	0.1%	N/A	0.113%
5/15/2026	Commodore Capital LP	3,275,000	$128.38M	7.4%	-30.2%	5.378%
5/15/2026	Affinity Asset Advisors LLC	586,904	$23.01M	1.2%	N/A	0.964%
5/15/2026	Entropy Technologies LP	6,101	$239K	0.0%	N/A	0.010%
5/15/2026	Spruce Street Capital LP	329,006	$12.90M	3.1%	-26.2%	0.540%
5/14/2026	Siren L.L.C.	746,226	$29.25M	0.8%	N/A	1.225%
5/14/2026	Walleye Capital LLC	37,827	$1.48M	0.0%	N/A	0.062%
5/7/2026	Dimensional Fund Advisors LP	681,715	$26.71M	0.0%	+70.9%	1.119%
5/7/2026	KBC Group NV	958	$38K	0.0%	N/A	0.002%
5/6/2026	Jennison Associates LLC	309,180	$12.12M	0.0%	N/A	0.508%
5/5/2026	Bank of New York Mellon Corp	120,057	$4.71M	0.0%	+8.6%	0.197%
5/1/2026	Candriam S.C.A.	594,079	$23.29M	0.1%	+31.1%	0.975%
4/24/2026	Capricorn Fund Managers Ltd	369,400	$14.48M	2.3%	N/A	0.607%
4/22/2026	Pictet Asset Management Holding SA	929,544	$36.44M	0.0%	-28.7%	1.526%
2/26/2026	Seven Fleet Capital Management LP	11,688	$180K	0.1%	N/A	0.020%
2/19/2026	Invesco Ltd.	24,720	$381K	0.0%	+7.0%	0.042%
2/18/2026	XTX Topco Ltd	60,702	$935K	0.0%	+472.6%	0.102%
2/18/2026	Vestal Point Capital LP	3,830,000	$58.98M	2.0%	+230.2%	6.454%
2/18/2026	Virtus Investment Advisers LLC	15,778	$243K	0.1%	+172.6%	0.027%
2/18/2026	Wellington Management Group LLP	129,876	$2M	0.0%	+19.6%	0.219%
2/18/2026	Susquehanna Portfolio Strategies LLC	48,741	$751K	0.0%	+53.6%	0.082%
2/18/2026	Tudor Investment Corp ET AL	29,673	$457K	0.0%	+82.0%	0.050%
2/18/2026	Sphera Funds Management LTD.	226,765	$3.49M	0.7%	+36.0%	0.382%
2/18/2026	Millennium Management LLC	296,947	$4.57M	0.0%	-22.1%	0.500%
2/18/2026	Janus Henderson Group PLC	1,671,724	$25.75M	0.0%	-6.8%	2.817%
2/18/2026	Baker BROS. Advisors LP	271,406	$4.18M	0.0%	+136.3%	0.457%
2/17/2026	ADAR1 Capital Management LLC	30,000	$462K	0.0%	N/A	0.051%
2/17/2026	Jump Financial LLC	45,354	$698K	0.0%	N/A	0.076%
2/17/2026	Price T Rowe Associates Inc. MD	23,800	$367K	0.0%	-89.7%	0.040%
2/17/2026	Rock Springs Capital Management LP	798,405	$12.30M	0.6%	+16.4%	1.345%
2/17/2026	California State Teachers Retirement System	32,206	$496K	0.0%	+58.4%	0.054%
2/17/2026	Russell Investments Group Ltd.	3,121	$48K	0.0%	-14.3%	0.005%
2/17/2026	State of Wisconsin Investment Board	20,398	$314K	0.0%	-57.2%	0.034%
2/17/2026	ExodusPoint Capital Management LP	60,415	$930K	0.0%	+25.5%	0.102%
2/17/2026	Polar Capital Holdings Plc	3,513,680	$54.11M	0.2%	+13.5%	5.920%
2/16/2026	Squarepoint Ops LLC	20,763	$320K	0.0%	-42.1%	0.035%
2/16/2026	Spruce Street Capital LP	446,084	$6.87M	2.3%	N/A	0.752%
2/16/2026	Barclays PLC	69,875	$1.08M	0.0%	-1.2%	0.118%
2/13/2026	Marshall Wace LLP	371,906	$5.73M	0.0%	+9.2%	0.627%
2/13/2026	The Manufacturers Life Insurance Company	19,336	$298K	0.0%	-56.1%	0.033%
2/13/2026	Exome Asset Management LLC	222,308	$3.42M	1.6%	N/A	0.375%
2/13/2026	Charles Schwab Investment Management Inc.	355,192	$5.47M	0.0%	-2.2%	0.598%
2/13/2026	State Street Corp	1,052,862	$16.21M	0.0%	+9.1%	1.774%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	55,210	$850K	0.0%	+6.8%	0.093%
2/13/2026	Wells Fargo & Company MN	43,056	$663K	0.0%	+66.7%	0.073%
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.
2/12/2026	Dimensional Fund Advisors LP	398,893	$6.14M	0.0%	+148.6%	0.672%
2/12/2026	Patient Square Capital LP	308,141	$4.75M	1.0%	+22.8%	0.519%
2/12/2026	New York State Common Retirement Fund	9,097	$140K	0.0%	-39.7%	0.015%
2/12/2026	Swiss National Bank	64,273	$990K	0.0%	+1.7%	0.108%
2/12/2026	Nuveen LLC	105,448	$1.62M	0.0%	-2.6%	0.178%
2/11/2026	Deutsche Bank AG	31,420	$484K	0.0%	+24.7%	0.053%
2/11/2026	Fox Run Management L.L.C.	12,432	$191K	0.0%	N/A	0.021%
2/11/2026	Franklin Resources Inc.	20,167	$311K	0.0%	-95.3%	0.034%
2/11/2026	Capital Research Global Investors	1,304,346	$20.09M	0.0%	-0.8%	2.198%
2/11/2026	Los Angeles Capital Management LLC	5,409	$83K	0.0%	N/A	0.009%

ELVN Institutional Ownership - Frequently Asked Questions

During the previous two years, 137 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were Spruce Street Capital LP ($16.70B), BlackRock Inc. ($221.26M), FMR LLC ($146.16M), California State Teachers Retirement System ($137.32M), Commodore Capital LP ($128.38M), Vestal Point Capital LP ($58.98M), and Polar Capital Holdings Plc ($54.11M).Learn more on Enliven Therapeutics' institutional investors.

95.08% of Enliven Therapeutics' stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Of the 119 institutional investors that purchased Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($4.36M), Vestal Point Capital LP ($3.58M), California State Teachers Retirement System ($2.69M), Polar Capital Holdings Plc ($2.20M), Affinity Asset Advisors LLC ($986.90K), Duquesne Family Office LLC ($947.41K), and FMR LLC ($801.30K).

Institutional investors have bought a total of 21,398,021 shares in the last 24 months. This purchase volume represents approximately $800.43M in transactions.

Of the 33 institutional investors that sold Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Janus Henderson Group PLC ($1.78M), Commodore Capital LP ($1.42M), Woodline Partners LP ($800.16K), Pictet Asset Management Holding SA ($468.54K), Franklin Resources Inc. ($410.07K), Citadel Advisors LLC ($309.92K), and Price T Rowe Associates Inc. MD ($207.50K).

Institutional investors have sold a total of 5,965,858 shares in the last 24 months. This volume of shares sold represents approximately $184.08M in transactions.

Related Companies

Institutional ownership data for NASDAQ:ELVN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/26/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enliven Therapeutics (ELVN) Institutional Ownership

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

ELVN Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enliven Therapeutics (ELVN) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

ELVN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELVN shares?

What percentage of Enliven Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Enliven Therapeutics' stock?

How much institutional buying is happening at Enliven Therapeutics?

Which of Enliven Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Enliven Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools